|
|
Grape King Bio Ltd
TAI •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 06/08/2026 13:30
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeTAI
Market Capitalization14,962 mln
Float116 mln
Relative Strength
41
/ 100
Slightly lagging
Key Fundamentals
EPS8.17
P/E12.24
ROE12.18
RPS68.80
ROIC17.20
ROA8.08
Interest Cover451
EBITDA, mln2,859
EV / EBITDA4.36
EV / EBIT5.42
Revenue, mln10,252
EV / Revenue1.23
Financial Strength
Altman Z-Score4.12
Piotroski F-Score
3
/ 9
Beneish M-Score-2.62
Price to Intrinsic Value0.56
Price to Graham Number0.90
Shiller PE Ratio9.09
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
0% |
64
/ 100
 |
| 1 Month |
-11.06% |
8
/ 100
 |
| 2 Months |
-18.95% |
8
/ 100
|
| 6 Months |
-18.98% |
9
/ 100
|
| 1 Year |
-20.27% |
18
/ 100
 |
|
| |
